The following data is part of a premarket notification filed by Asuragen, Inc. with the FDA for Rnaretain.
Device ID | K113420 |
510k Number | K113420 |
Device Name: | RNARETAIN |
Classification | Tissue Rna Preservative For Collection, Storage, And Transportation |
Applicant | ASURAGEN, INC. 2150 WOODWARD ST. SUITE 100 Austin, TX 78744 -1840 |
Contact | Luc Van Hove |
Correspondent | Luc Van Hove ASURAGEN, INC. 2150 WOODWARD ST. SUITE 100 Austin, TX 78744 -1840 |
Product Code | OZF |
CFR Regulation Number | 866.4070 [🔎] |
Decision | Substantially Equivalent (SESE) |
Type | Traditional |
3rd Party Reviewed | No |
Combination Product | No |
Date Received | 2011-11-18 |
Decision Date | 2012-03-16 |
Summary: | summary |
Device Identifier | submissionNumber | Supplement |
---|---|---|
00863840000285 | K113420 | 000 |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
![]() RNARETAIN 77209982 3689865 Live/Registered |
Asuragen, Inc. 2007-06-19 |